T Nakahata
Overview
Explore the profile of T Nakahata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
257
Citations
3029
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abe S, Asami S, Eizuka M, Futagi S, Gando A, Gando Y, et al.
Phys Rev Lett
. 2023 Feb;
130(5):051801.
PMID: 36800472
The KamLAND-Zen experiment has provided stringent constraints on the neutrinoless double-beta (0νββ) decay half-life in ^{136}Xe using a xenon-loaded liquid scintillator. We report an improved search using an upgraded detector...
2.
Tsuji K, Nakahata T
Hematology
. 2016 Jul;
2(2):143-9.
PMID: 27406805
A complex of soluble interleukin-6 receptor (sIL-6R) and interleukin-6 has been shown to play some roles in human hematopoiesis. It activates gp130 signal to stimulate human erythroid, megakaryocytic and primitive...
3.
Nodomi S, Umeda K, Saida S, Kinehara T, Hamabata T, Daifu T, et al.
Oncogene
. 2016 Apr;
35(40):5317-5327.
PMID: 27041577
Malignant rhabdoid tumor (MRT) is a rare, highly aggressive pediatric malignancy that primarily develops during infancy and early childhood. Despite the existing standard of intensive multimodal therapy, the prognosis of...
4.
Sakashita K, Kato I, Daifu T, Saida S, Hiramatsu H, Nishinaka Y, et al.
Leukemia
. 2014 Aug;
29(3):606-14.
PMID: 25102944
Using serum-containing culture, we examined whether AGM-S3 stromal cells, alone or in combination with hematopoietic growth factor(s), stimulated the proliferation of CD34(+) cells from patients with juvenile myelomonocytic leukemia (JMML)....
5.
Kodera Y, Yamamoto K, Harada M, Morishima Y, Dohy H, Asano S, et al.
Bone Marrow Transplant
. 2013 Oct;
49(2):195-200.
PMID: 24076552
Severe adverse events (SAE) and late hematological malignancies have been reported after PBSC donation. No prospective data on incidence and risk factors have been available for family donors so far....
6.
Tomizawa D, Tawa A, Watanabe T, Saito A, Kudo K, Taga T, et al.
Leukemia
. 2013 May;
27(12):2413-6.
PMID: 23677335
No abstract available.
7.
Nakazawa Y, Saito S, Yanagisawa R, Suzuki T, Ito T, Ishida F, et al.
Bone Marrow Transplant
. 2012 Oct;
48(5):737-9.
PMID: 23103682
No abstract available.
8.
Kita F, Shibata Y, Yorifuji T, Nakahata T, Kawakami J, Kawakami K
J Clin Pharm Ther
. 2010 Feb;
35(1):87-92.
PMID: 20175816
Objective: We aimed to investigate recent trends in prescriptions for the treatment of paediatric gastroenteritis in Japan over a 10-year period (1997-2007). Methods: In this retrospective cohort study, we collected...
9.
Takeuchi M, Kimura S, Kuroda J, Ashihara E, Kawatani M, Osada H, et al.
Cell Death Differ
. 2010 Feb;
17(7):1211-20.
PMID: 20139893
Abl tyrosine kinase inhibitors (TKIs) such as imatinib and dasatinib are ineffective against Bcr-Abl(+) leukemic stem cells. Thus, the identification of novel agents that are effective in eradicating quiescent Bcr-Abl(+)...
10.
Oki E, Tsuruga K, Tsugawa K, Suzuki K, Shinagawa T, Nakahata T, et al.
Clin Nephrol
. 2008 Oct;
70(4):354-6.
PMID: 18826863
No abstract available.